Cargando…
Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial
Background: Antihypertensive drugs affect mineral metabolism, inflammation, and the oxidative state. The aim of this study was to evaluate the effects of antihypertensive monopharmacotherapy with diuretics, β-blockers, calcium antagonists (Ca-antagonists), angiotensin-converting enzyme inhibitors (A...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164079/ https://www.ncbi.nlm.nih.gov/pubmed/30208601 http://dx.doi.org/10.3390/nu10091284 |
_version_ | 1783359514735542272 |
---|---|
author | Suliburska, Joanna Skrypnik, Katarzyna Szulińska, Monika Kupsz, Justyna Markuszewski, Leszek Bogdański, Paweł |
author_facet | Suliburska, Joanna Skrypnik, Katarzyna Szulińska, Monika Kupsz, Justyna Markuszewski, Leszek Bogdański, Paweł |
author_sort | Suliburska, Joanna |
collection | PubMed |
description | Background: Antihypertensive drugs affect mineral metabolism, inflammation, and the oxidative state. The aim of this study was to evaluate the effects of antihypertensive monopharmacotherapy with diuretics, β-blockers, calcium antagonists (Ca-antagonists), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin II receptor antagonists (ARBs) on zinc (Zn), iron (Fe), and copper (Cu) status, parameters of oxidative and inflammatory states, and glucose and lipid metabolism in patients with newly diagnosed primary arterial hypertension (AH). Methods: Ninety-eight hypertensive subjects received diuretics, β-blockers, Ca-antagonists, ACE-I, or ARB for three months. Zn, Fe, and Cu concentrations were determined in blood, urine, and hair. Results: A decrease in zinc serum and erythrocyte concentration and an increase in zinc urine concentration were registered after diuretic administration. Ca-antagonists led to a decrease in erythrocyte zinc concentration. A decrease in serum zinc concentration was observed after ACE-I. A decrease in triglyceride serum concentration was noted after ACE-I therapy, and a decrease in tumor necrosis factor-α serum concentration was seen following administration of Ca-antagonists. Hypotensive drugs led to decreases in catalase and superoxide dismutase serum concentrations. Conclusions: Three-months of monotherapy with diuretics, Ca-antagonists, or ACE-I impairs zinc status in patients with newly diagnosed primary AH. Antihypertensive monopharmacotherapy and zinc metabolism alterations affect lipid metabolism, the oxidative state, and the inflammatory state. |
format | Online Article Text |
id | pubmed-6164079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61640792018-10-10 Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial Suliburska, Joanna Skrypnik, Katarzyna Szulińska, Monika Kupsz, Justyna Markuszewski, Leszek Bogdański, Paweł Nutrients Article Background: Antihypertensive drugs affect mineral metabolism, inflammation, and the oxidative state. The aim of this study was to evaluate the effects of antihypertensive monopharmacotherapy with diuretics, β-blockers, calcium antagonists (Ca-antagonists), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin II receptor antagonists (ARBs) on zinc (Zn), iron (Fe), and copper (Cu) status, parameters of oxidative and inflammatory states, and glucose and lipid metabolism in patients with newly diagnosed primary arterial hypertension (AH). Methods: Ninety-eight hypertensive subjects received diuretics, β-blockers, Ca-antagonists, ACE-I, or ARB for three months. Zn, Fe, and Cu concentrations were determined in blood, urine, and hair. Results: A decrease in zinc serum and erythrocyte concentration and an increase in zinc urine concentration were registered after diuretic administration. Ca-antagonists led to a decrease in erythrocyte zinc concentration. A decrease in serum zinc concentration was observed after ACE-I. A decrease in triglyceride serum concentration was noted after ACE-I therapy, and a decrease in tumor necrosis factor-α serum concentration was seen following administration of Ca-antagonists. Hypotensive drugs led to decreases in catalase and superoxide dismutase serum concentrations. Conclusions: Three-months of monotherapy with diuretics, Ca-antagonists, or ACE-I impairs zinc status in patients with newly diagnosed primary AH. Antihypertensive monopharmacotherapy and zinc metabolism alterations affect lipid metabolism, the oxidative state, and the inflammatory state. MDPI 2018-09-11 /pmc/articles/PMC6164079/ /pubmed/30208601 http://dx.doi.org/10.3390/nu10091284 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Suliburska, Joanna Skrypnik, Katarzyna Szulińska, Monika Kupsz, Justyna Markuszewski, Leszek Bogdański, Paweł Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
title | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
title_full | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
title_fullStr | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
title_full_unstemmed | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
title_short | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
title_sort | diuretics, ca-antagonists, and angiotensin-converting enzyme inhibitors affect zinc status in hypertensive patients on monotherapy: a randomized trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164079/ https://www.ncbi.nlm.nih.gov/pubmed/30208601 http://dx.doi.org/10.3390/nu10091284 |
work_keys_str_mv | AT suliburskajoanna diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT skrypnikkatarzyna diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT szulinskamonika diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT kupszjustyna diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT markuszewskileszek diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT bogdanskipaweł diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial |